Phase 2 Bone Metastases Clinical Trials

4 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–4 of 4 trials

Recruiting

Phase 2

Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: A Randomized Trial

RadiotherapyBone Metastases in Subjects With Advanced Cancer

Roxanne Gal246 enrolled5 locationsNCT06805396

Recruiting

Phase 2

A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors

For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.210 enrolled1 locationNCT07028268

Recruiting

Phase 2

Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study

Triple-Negative Breast CancerBone Metastases

Zhejiang Cancer Hospital20 enrolled1 locationNCT06538896

Recruiting

Phase 1Phase 2

Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer

Breast CancerBone Metastases

Fudan University120 enrolled1 locationNCT04947280